luxembourg deal news - gsk stockmann · deal news . page 1 of 2 . luxembourg gsk luxembourg sa 44,...
TRANSCRIPT
Deal news
Page 1 of 2
LUXEMBOURG GSK Luxembourg SA 44, Avenue John F. Kennedy L-1855 Luxemburg Tel +352 2718 0200 Fax +352 2781 0211 [email protected]
Luxembourg, 10 October 2016 GSK Stockmann in Luxembourg advised Grand City Proper-ties in connection with the issuance and private placement of EUR 200 million notes listed on the regulated market of the Irish Stock Exchange GSK Stockmann in Luxembourg advised Grand City Properties as to Luxem-bourg corporate, capital markets and tax law in connection with the issuance and private placement of EUR 200 million notes listed on the regulated market of the Irish Stock Exchange. Morgan Stanley acted as the underwriter. On 22 September 2016 Grand City Properties S.A. issued EUR 200 million undated unsecured subordinated notes with a coupon of 2.75% (the "Notes"). The German law governed Notes in denominations of EUR 100,000 were exclusive-ly offered to institutional investors and admitted for trading on the regulated market of the the Irish Stock Exchange. Settlement took place on 22 September 2016. Grand City Properties is a specialist real estate company focused on investing in and managing value-add opportunities in the real estate property market in Germa-ny, primarily in densely populated areas. GSK Stockmann comprehensively advised Grand City Properties, in particular on Luxembourg corporate, capital markets and tax issues. Advisor to Grand City Properties S.A.: GSK Luxembourg SA as to Luxembourg law: Dr. Philipp Mößner (Lead, Corporate and Capital Markets), Mathilde Ostertag (Tax). Associates: Thao Nguyen, Benedikt Kreuder (both Corporate)
Page 2 of 2
Contact: GSK LUXEMBOURG SA Dr. Philipp Mößner 44, Avenue John F. Kennedy L-1855 Luxemburg Tel.: +352 2718 0200 Fax: +352 2781 0211 E-Mail: [email protected] GSK Stockmann is a leading, independent commercial law firm with international reach and offices in Berlin, Frankfurt am Main, Hamburg, Heidelberg, Munich, Brus-sels and Luxembourg. Today, our clients can call upon more than 150 lawyers with outstanding reputation handling both national and international work for our clients. The Luxembourg office advises international and domestic clients across a wide range of areas in relation to Corporate/M&A, Private Equity, Investment Funds, Cap-ital Markets, Banking/Finance, Regulatory, Real Estate, Insurance and Tax. For further information, please visit: www.gsk.de/en/gsk-luxembourg In cross-border transactions, GSK cooperates closely with the members of the Broadlaw Group, a selected circle of reputable law firms encompassing the most significant European jurisdictions. These law firms are Lefèvre Pelletier & associés (France), Nabarro LLP (UK), Nunziante Magrone (Italy) and Roca Junyent (Spain). This exclusive network includes more than 1000 lawyers, based in 30 cities, cover-ing the most important financial and economic centres of Europe, Asia, the Middle East and Africa. For further information, please visit: www.broadlawgroup.com
GSK. The Difference.